Soligenix
SNGX
#10223
Rank
$16.23 M
Marketcap
$1.61
Share price
-1.23%
Change (1 day)
-49.69%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : $0.38 Million USD

According to Soligenix's latest financial reports the company's total debt is $0.38 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$1.48 M-57.51%
2023-12-31$3.49 M-65.87%
2022-12-31$10.24 M2.79%
2021-12-31$9.96 M-5.18%
2020-12-31$10.5 M8158%
2019-12-31$0.12 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31$0.29 M-92.28%
2014-12-31$3.78 M-54.24%
2013-12-31$8.28 M
2004-12-31$0.11 M-67.71%
2003-12-31$0.35 M-50.81%
2002-12-31$0.72 M236.63%
2001-12-31$0.21 M-32.86%
2000-12-31$0.32 M-17.66%
1999-12-31$0.39 M-1.94%
1998-12-31$0.4 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$25.53 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
$60.84 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$45.79 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
$18.57 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel